Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Shares Outstanding (Diluted Average) (2022 - 2025)

Dna X's Shares Outstanding (Diluted Average) history spans 4 years, with the latest figure at $722689.0 for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $722689.0 for Q4 2025, up 175.71% from a year ago — trailing twelve months through Dec 2025 was $722689.0 (up 175.71% YoY), and the annual figure for FY2025 was $722689.0, up 175.71%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $722689.0 at Dna X, up from $614985.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $41.1 million in Q1 2023 to a low of $258788.0 in Q3 2024.
  • The 4-year median for Shares Outstanding (Diluted Average) is $4.5 million (2024), against an average of $11.5 million.
  • The sharpest move saw Shares Outstanding (Diluted Average) tumbled 94.14% in 2024, then soared 175.71% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $28.9 million in 2022, then plummeted by 85.16% to $4.3 million in 2023, then plummeted by 93.89% to $262118.0 in 2024, then soared by 175.71% to $722689.0 in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $722689.0, $614985.0, and $9.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.